Diabetes, Medication Management
Beyond Glycemic Management: The Pharmacist’s Role in Optimizing Cardiovascular and Renal Outcomes in People with Type 2 Diabetes
Managing type 2 diabetes has increased in complexity over the last several years. This case-based practical program is designed to provide healthcare professionals with a quick update on the optimal management of people with type 2 diabetes who have chronic kidney disease or are at high-risk of cardiovascular disease.
DURATION
30 min
PROFESSION
Pharmacy
# OF CREDITS
1.5
ACCREDITATION
CCCEP, OPQ
EXPIRY DATE
2025-10-01
Optimal management of people with type 2 diabetes has increased in complexity over the last several years. The focus is not only on the management of hyperglycemia, but also on interventions that have been associated with a reduction in the development and progression of complications such as cardiovascular disease and chronic kidney disease. This program is focused on providing clinicians with a quick update on the optimal management of individuals with type 2 diabetes with chronic kidney disease or at high-risk of cardiovascular disease. This case-based practical program will provide healthcare professionals with a quick update on these topics to allow them to apply evidence-informed care in practice.
Faculty
- Ronald Goldenberg, MD, FRCPC, FACE
- Robert Hauptman, BMSc, MD, MCFP
- Sofia Nastis, BMSc, MD, CCFP
- Jahan Lakhani, MD, CCFP
- Bilal Hatoum, BSc Pharm, RPh, APA, CDE
- Susie Jin, RPh, CDE, CRE
Learning objectives
Upon successful completion of this continuing education activity, you will be better able to:
- Analyze the components of the ABCDESSS approach in managing individuals with type 2 diabetes at high risk for cardiovascular disease
- Create treatment plans for adults with type 2 diabetes and chronic kidney disease or cardiovascular risk factors, integrating pharmacological interventions, lifestyle modifications, and regular monitoring strategies
- Evaluate the appropriateness of using SGLT2 inhibitors, GLP-1 receptor agonists, and non-steroidal mineralocorticoid receptor antagonists in adults with type 2 diabetes and chronic kidney disease, based on current evidence and guideline recommendations
- Apply evidence-based strategies to adjust antihyperglycemic agents and manage potential side effects in people with type 2 diabetes and varying levels of renal function
Accreditation
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1.5 CEU(s). CCCEP File Number: 1066-2024-3857-I-P.
This continuing educational activity has been accredited by the OPQ; 1.5 continuing education units/credits will be awarded to pharmacists who successfully complete the program. Accreditation number: 240134
# of credits: 1.5 
Duration: 30 min FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
30 min
Duration
Pharmacy
Profession
1.5
# of credits
Learning Objectives
Upon successful completion of this continuing education activity, you will be better able to:
- Analyze the components of the ABCDESSS approach in managing individuals with type 2 diabetes at high risk for cardiovascular disease
- Create treatment plans for adults with type 2 diabetes and chronic kidney disease or cardiovascular risk factors, integrating pharmacological interventions, lifestyle modifications, and regular monitoring strategies
- Evaluate the appropriateness of using SGLT2 inhibitors, GLP-1 receptor agonists, and non-steroidal mineralocorticoid receptor antagonists in adults with type 2 diabetes and chronic kidney disease, based on current evidence and guideline recommendations
- Apply evidence-based strategies to adjust antihyperglycemic agents and manage potential side effects in people with type 2 diabetes and varying levels of renal function
CCCEP
Accredited
Course
CCCEP, OPQ
ACCREDITATION
Diabetes, Medication Management
Learning Category
Diabetes, CKD
Topic
0
Price
2025-10-01
Expiry Date
CAN-eng
Region/Language
Course Description
Optimal management of people with type 2 diabetes has increased in complexity over the last several years. The focus is not only on the management of hyperglycemia, but also on interventions that have been associated with a reduction in the development and progression of complications such as cardiovascular disease and chronic kidney disease. This program is focused on providing clinicians with a quick update on the optimal management of individuals with type 2 diabetes with chronic kidney disease or at high-risk of cardiovascular disease. This case-based practical program will provide healthcare professionals with a quick update on these topics to allow them to apply evidence-informed care in practice.
Faculty
- Ronald Goldenberg, MD, FRCPC, FACE
- Robert Hauptman, BMSc, MD, MCFP
- Sofia Nastis, BMSc, MD, CCFP
- Jahan Lakhani, MD, CCFP
- Bilal Hatoum, BSc Pharm, RPh, APA, CDE
- Susie Jin, RPh, CDE, CRE
Accreditation
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1.5 CEU(s). CCCEP File Number: 1066-2024-3857-I-P.
This continuing educational activity has been accredited by the OPQ; 1.5 continuing education units/credits will be awarded to pharmacists who successfully complete the program. Accreditation number: 240134
30 min
Duration
0
Price
1.5
# of credits
